TOP STORIES

• COMMENTARY Goals of the “Innovation Box” Tax Break in FY2024 Reform
  January 23, 2024

• ACADEMIA Expert Charts Future of Alzheimer’s Treatment with More Drugs in Wings to Follow Leqembi
  January 22, 2024

• BUSINESS LEO Pharma Poised to Build Presence in Japan as Dermatology Leader: CEO
  January 19, 2024

• REGULATORY Market Expansion Re-Pricing to Hit 23 Meds in April, Opdivo Faces Yet Another Cut in Spillover
  January 18, 2024

• BUSINESS Sawai Exits US Biz to Cope with GMP and Supply Issues in Japan
  January 18, 2024

• BUSINESS Ono Deplores Regulator’s Decision on Opdivo Spillover Re-Pricing
  January 18, 2024

• BUSINESS Daiichi Sankyo to Discontinue Sales of Herceptin Biosimilar in November
  January 17, 2024

• REGULATORY MHLW Issues Notification to Clarify Orphan Designation Criteria
  January 17, 2024

• COMMENTARY Introduction of Elective Care to Mark Watershed for Long-Listed Drug Makers
  January 17, 2024

• REGULATORY FY2024 Reform Will Bolster Rewards for Innovation to Eradicate Drug Lag/Loss: LDP Policy Bigwig
  January 16, 2024

• REGULATORY New LLP Coverage Rule Aimed to Transform Industry Rather Than Eke Out Savings: LDP Social Security Chief
  January 15, 2024

• BUSINESS GSK’s Arexvy Hits Market as Japan’s 1st RSV Vaccine
  January 15, 2024

• BUSINESS Ono Poised to Overcome Opdivo Patent Cliff and Go Fully Global under New President
  January 12, 2024

• REGULATORY MHLW Study Underway on Lab Monkey Shortage, Research Team Frets Dependence on Specific Sources
  January 11, 2024

• BUSINESS New LLP Coverage Rule Loathed by Off-Patent Drug Makers but Innovative Players Hail Reform
  January 10, 2024

• REGULATORY Handling of Big-Seller Candidates Is Top Priority as Japan Seeks Good Budget Balance: Minister
  January 10, 2024

• ORGANIZATION FPMAJ Stands Firmly Against Full Implementation of Off-Year Price Revision in FY2025
  January 9, 2024

• BUSINESS Santen, Astellas, 3 More Firms Hit by Manufacturing Delays after Quake
  January 9, 2024

• BUSINESS Equa, Betanis and More Brands Gird for Generic Entry in 2024; Xarelto Contenders Too?
  January 5, 2024

• BUSINESS After New Year’s Quake, Wholesalers See Challenges in Drug Delivery to North Part of Noto Peninsula
  January 5, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• …
• Next ›
• 最終 »